Mark Smith of Finch Therapeutics is the youngest CEO in biotech. That alone is evidence that this young, progressive organization are challenging the conventions of an industry that is notoriously hierarchical and stuck in the belief that experience can only come with age.
So what does being the youngest CEO mean for the culture of Finch Therapeutics? How are things done differently and what does success look like for its leaders and people?
Have a listen to our latest Podcast on Saying no to the status quo with Mark Smith, Finch Therapeutics and Alex Cooke our Founder here at Phase 3.